10-K.Info (Beta Test)
Courtesy of Short Sands, LLC
10-K.Info (Beta Test)
Courtesy of Short Sands, LLC

ELEVANCE HEALTH, INC.

Ticker: ELV   Fiscal Year: 2014

Consolidated Statements of Cash Flows

Period Ending Dec 31, 2014 10-K (Filed: Feb 24, 2015)

(In Thousands, except shares in actual)
 12 Months Ended12 Months Ended12 Months Ended
 Dec 31, 2014Dec 31, 2013Dec 31, 2012
Operating activities
Net income
$
2,569,700
2,489,7002,655,500
Adjustments to reconcile net income to net cash provided by operating activities:
Net realized gains on investments(177,000)(271,900)(334,900)
Other-than-temporary impairment losses recognized in income49,00098,90037,800
Loss on extinguishment of debt81,100145,3000
(Gain) loss on disposal from discontinued operations(3,200)221,8000
(Gain) loss on disposal of assets(1,700)3,9004,700
Deferred income taxes30,70059,100127,500
Amortization, net of accretion744,500800,900633,600
Depreciation expense106,500107,900107,100
Impairment of property and equipment7,90047,70066,800
Share-based compensation168,900146,000146,500
Excess tax benefits from share-based compensation(46,400)(30,100)(28,800)
Changes in operating assets and liabilities:
Receivables, net(1,899,700)(418,300)189,900
Other invested assets(21,700)(15,100)(38,900)
Other assets405,500(33,600)79,200
Policy liabilities1,240,600(345,800)(53,700)
Unearned income255,100(73,800)(193,700)
Accounts payable and accrued expenses(14,400)303,600(406,500)
Other liabilities(7,900)(154,600)(132,800)
Income taxes(34,000)9,300(73,900)
Other, net(84,200)(38,600)(40,800)
Net cash provided by operating activities3,369,3003,052,3002,744,600
 
Investing activities
Purchases of fixed maturity securities(9,613,400)(13,704,500)(15,040,400)
Proceeds from fixed maturity securities:
Sales8,066,00010,977,90013,675,900
Maturities, calls and redemptions1,318,7001,836,8001,781,500
Purchases of equity securities(912,000)(820,300)(232,800)
Proceeds from sales of equity securities746,500721,000422,700
Purchases of other invested assets(205,700)(251,500)(303,700)
Proceeds from sales of other invested assets124,700127,10035,500
Settlement of non-hedging derivatives(67,400)(109,800)(59,800)
Changes in securities lending collateral(545,600)(405,100)307,900
Purchases of subsidiaries, net of cash acquired00(4,597,000)
Proceeds from sale of subsidiary, net of cash sold740,00000
Purchases of property and equipment(714,600)(646,500)(544,900)
Proceeds from sales of property and equipment88,00039,200400
Other, net(100)1,3003,100
Net cash used in investing activities(974,900)(2,234,400)(4,551,600)
 
Financing activities
Net repayments of commercial paper borrowings(379,200)(191,700)(229,000)
Proceeds from long-term borrowings2,700,0001,250,0006,468,900
Repayments of long-term borrowings(1,730,100)(1,801,900)(1,251,300)
Proceeds from short-term borrowings2,050,0001,100,000642,000
Repayments of short-term borrowings(2,050,000)(950,000)(492,000)
Changes in securities lending payable545,600405,000(307,800)
Changes in bank overdrafts173,0009,900(17,600)
Premiums paid on equity options0(25,800)0
Repurchase and retirement of common stock(2,998,800)(1,620,100)(2,496,800)
Cash dividends(480,700)(448,000)(367,100)
Proceeds from issuance of common stock under employee stock plans301,300524,700110,800
Excess tax benefits from share-based compensation46,40030,10028,800
Net cash (used in) provided by financing activities(1,822,500)(1,717,800)2,088,900
 
Effect of foreign exchange rates on cash and cash equivalents(7,100)2,2001,100
Change in cash and cash equivalents564,800(897,700)283,000
 
Cash and cash equivalents at beginning of year1,586,9002,484,600
Cash and cash equivalents at end of year2,151,7001,586,9002,484,600
 
Less cash and cash equivalents of discontinued operations at end of year0(4,800)(9,300)
Cash and cash equivalents of continuing operations at end of year2,151,7001,582,1002,475,300
 
External Links 
ELEVANCE HEALTH, INC. (ELV) Fiscal Year 2014
Statements of 10-K in Excel https://www.sec.gov/.../Financial.xlxs
Complete 10-K in HTML https://www.sec.gov/.../10-K.html
Complete 10-K in XBRL https://www.sec.gov/.../10-K-xbrl.zip